CareDx (NASDAQ: CDNA) reported Q2 EPS of ($0.18), $0.36 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $70.3 million versus the consensus estimate of $61.77 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.